ArticleInternational journal of dermatology2025
The Use of Morphology-Directed Targeted Immunosuppression With Dupilumab in Cutaneous Immunotherapy Related Adverse Events.
Brittany Dulmage et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.